SEARCH

SEARCH BY CITATION

References

  • Black, J.W. & Leff, P. (1983). Operational models of pharmacological agonism. Proc. R. Soc. B., 220, 141162.
  • Black, J.W., Leff, P., Shankley, N.P. & Wood, J. (1985). An operational model of agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation. Br. J. Pharmacol., 84, 561571.
  • Boyer, J.L., O'Tuel, J.W., Fischer, B., Jacobsen, K.A. & Harden, T.K. (1995). Potent agonist action of 2-thioether derivatives of adenine nucleotides at adenylyl cyclase-linked P2Y-receptors. Br. J. Pharmacol., 116, 26112616.
  • Boyer, J.L., Robero-Avila, T., Schachter, J.B. & Harden, T.K. (1996). Identification of competitive antagonists of the P2Y1-receptor. Mol. Pharmacol., 50, 13231329.
  • Burnstock, G. & King, B.F. (1996). Numbering of cloned P2 receptors. Drug Dev. Res., 38, 6771.
  • Cattaneo, M., Lecchi, A., Randi, A.M., Mcgregor, J.L. & Mannuci, P.M. (1992). Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. Blood, 80, 27872796.
  • Conley, P., Vincent, D., Tai, A., Bhaskar, V., Li, G., Chiu, E., Kartik, A. & Jantzen, H.M. (1996). Cloning of two receptors from a human megakaryocytic cell line. Drug Dev. Res., 37, 111.
  • Cusack, N.J. & Hourani, S.M.O. (1982). Adenosine 5′-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors. Br. J. Pharmacol., 76, 221227.
  • Cusack, N.J. & Pettey, C.J. (1996). Effects of phosphate-modified analogs of adenosine 5′-diphosphate and adenosine 5′-triphosphate at P2T-receptors mediating human platelet activation by ADP. Drug Dev. Res., 37, 212222.
  • Dainty, I.A., Dougall, I.G., Mckay, G.D. & Leff, P. (1997). Pharmacological characterisation of a cloned bovine P2Y1-purinoceptor transfected into Jurkat cells. Br. J. Pharmacol., 120, 299P.
  • Feolde, E., Vigne, P., Breittmayer, J.P. & Frelin, C. (1995). ATP, a partial agonist of atypical P2Y receptors in rat brain microvascular endothelial cells. Br. J. Pharmacol., 115, 11991203.
  • Filtz, T.M., Li, Q., Boyer, J.L., Nicholas, R.A. & Harden, T.K. (1994). Expression of a cloned P2Y purinergic receptor that couples to phospholipase C. Mol. Pharmacol., 46, 814.
  • Fredholm, B.B., Abbracchio, M.P., Burnstock, G., Dubyak, G.R., Harden, T.K., Jacobson, K.A., Schwabe, U. & Williams, M. (1997). Towards a revised nomenclature for P1 and P2 receptors. Trends Pharmacol. Sci., 18, 7982.
  • Gabberta, J., Yang, X., Kowalska, M.A., Sun, L. & Dhanasekaran, N. (1997). Platelet signal transduction defect with Gα subunit dysfunction and diminished Gαq in a patient with abnormal platelet responses. Proc. Natl. Acad. Sci. U.S.A., 94, 87508755.
  • Gachet, C., Cattaneo, M., Ohlmann, P., Hechler, B., Lecchl, A., Chevalier, J., Cassel, D., Mannuccio, P.M. & Cazenave, J.P. (1995). Receptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors. Br. J. Haematol., 91, 434444.
  • Gachet, C., Cazenave, J-P., Ohlmann, P., Bouloux, C., Defreyn, G., Driot, F. & Maffrand, J.P. (1990). The thienopyridine ticlopidine selectively prevents the inhibitory effects of ADP but not of adrenaline on cAMP levels raised by stimulation of the adenylate cyclase of human platelets by PGE1. Biochem. Pharmacol., 40, 26832687.
  • Gachet, C., Hechler, B., Leon, C., Vial, C., Leray, C., Ohlmann, P. & Cazenave, J. (1997). Activation of ADP receptors and platelet function. Thromb. Haemost., 78, 271275.
  • Gear, A.R.L. (1993). Platelet adhesion, shape change and aggregation: rapid initiation and signal transduction events. Can. J. Physiol. Pharmacol., 72, 285294.
  • Hall, D.A. & Hourani, S.M.O. (1993). Effects of analogues of adenine nucleotides on increase in intracellular calcium mediated by P2T-receptors on human blood platelets. Br. J. Pharmacol., 108, 728733.
  • Henderson, D.J., Elliot, D.G., Smith, G.M., Webb, T.E. & Dainty, I.A. (1995). Cloning and characterisation of a bovine P2Y receptor. Biochim. Biophys. Res. Commun., 212, 648656.
  • Hourani, S.M.O. & Cusack, N.J. (1991). Pharmacological receptors on blood platelets. Pharmacol. Rev., 43, 243298.
  • Hourani, S.M.O. & Hall, D.A. (1994). Receptors for ADP on human blood platelets. Trends Pharmacol. Sci., 15, 103108.
  • Humphries, R.G., Tomlinson, W., Ingall, A.H., Cage, P.A. & Leff, P. (1994). FPL 66096LT: a novel, highly potent and selective antagonist at human platelet P2T-receptors. Br. J. Pharmacol., 113, 10571063.
  • Leff, P., Prentice, D.J., Giles, H., Martin, G.R. & Wood, J. (1990). Estimation of agonist affinity and efficacy by direct, operational model-fitting. J. Pharmacol. Methods, 23, 225237.
  • Léon, C., Hechler, B., Vial, C., Leray, C., Cazenave, J-P. & Gachet, C. (1997). The P2Y1 receptor is an ADP receptor antagonised by ATP and expressed in platelets and megakaryo-blastic cells. FEBS Lett., 403, 2630.
  • Mackenzie, A.M., Mahaut-Smith, M.P. & Sage, S.O. (1996). Activation of receptor-operated cation channels via P2X1 not P2T receptors in human platelets. J. Biol. Chem., 271, 28792881.
  • Murgo, A.J., Contrera, J.G. & Sistare, F.D. (1994). Evidence for separate calcium-signaling P2T and P2U receptors in human megakaryocytic Dami cells. Blood, 83, 12581267.
  • Murgo, A.J. & Sistare, F.D. (1992). K562 leukemia cells express P2T (adenosine di-phosphate) purinergic receptors. J. Pharmacol. Exp. Ther., 261, 580585.
  • Nicholas, R.A., Watt, W.C., Lazarowski, E.R., Li, Q. & Harden, T.K. (1996). Uridine nucleotide selectivity of three phospholipase C-activating P2-receptors: Identification of a UDP-selective, a UTP-selective and an ATP- and UTP-specific receptor. Mol. Pharmacol., 50, 224229.
  • Offermanns, S., Toombs, C.F., Hu, Y. & Simon, M. (1997). Defective platelet activation in Gαq-deficient mice. Nature, 389, 183186.
  • Sanderson, H.M., Hepinstall, S., Vickers, J. & Losche, W. (1996). Studies on the effects of agonists and antagonists on platelet shape change and platelet aggregation in whole blood. Blood Coag. Fibrinol., 7, 245248.
  • Sargeant, P. & Sage, S.O. (1994). Calcium signalling in platelets and other nonexcitable cells. Pharmacol. Ther., 64, 395443.
  • Schachter, J.B., Boyer, J.L., Li, Q., Nicholas, A. & Harden, T.K. (1997). Fidelity in functional coupling of the rat P2Y1 receptor to phospholipase C. Br. J. Pharmacol., 122, 10211024.
  • Sistare, F.D., Rosenzweig, B.A., Contrera, J.G. & Jordan, B. (1994). Separate P2T and P2U purinergic receptors with similar second messenger signalling pathways in UMR-106 osteoblasts. J. Pharmacol. Exp. Ther., 269, 10491061.
  • Stone, M. & Angus, J.A. (1978). Development of computer-based estimation of pA2 values and associated analysis. J. Pharmacol. Exp. Ther., 207, 705718.
  • Tomlinson, W., Humphries, R.G., Robertson, M.J. & Leff, P. (1997). ARL 67085 and ARL 66096 are slowly dissociating competitive P2T-purinoceptor antagonists. Br. J. Pharmacol., 120, 131P.
  • Trist, D.J. & Leff, P. (1985). Quantification of H2-agonism by clonidine and dimaprit in an adenylate cyclase assay. Agents Actions, 16, 222226.